Tuesday, August 11, 2015 9:35:06 AM
Mark and Rene Schena are brilliant innovators who are very passionate about their dreams and what the microarray technology they have created. In fact, this technology is being used by MANY research institutions, BIG pharma companies, hospitals, and the USDA.
But, I agree they aren't the best business people- most intelligent scientists aren't. They looked to dilution and convertible debts as a way to keep their company afloat long enough for their incredible technology to be acknowledged and supported.
427 million shares in the OS, less than 400m shares in the float, A/S 480m (almost maxed out).
90%< of start-up companies don't make it, often due to poor business methods and lack of revenues/bankruptcy.
I know this company has a lot in the pipeline and I'm mainly waiting on FDA approval news. This company WILL surprise a lot of people.
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • BURU • Oct 15, 2024 8:21 AM